PharmaNet Development Group

Marc Kamin, M.D., has been appointed vice president, Medical and Scientific Affairs, Neuroscience, PharmaNet Development Group. Dr. Kamin will advise clients in the area of neuroscience and will provide medical support to PharmaNet project teams conducting neuroscience clinical studies.

Dr. Kamin is a neurologist, certified by the American Board of Psychiatry and Neurology, and has 20 years of experience in the pharmaceutical industry. Most recently, he led the Central Trial Coordination group for Medical Affairs in Global Clinical Operations at Johnson & Johnson. Dr. Kamin has designed and managed trials in many areas of neuroscience including migraine, eating disorders, bipolar disorder, alcohol addiction, acute and chronic pain, multiple sclerosis, epilepsy, peripheral neuropathy, amyotrophic lateral sclerosis and fibromyalgia.

“We are delighted to have a physician of his caliber at the forefront of our neuroscience team,” commented Dr. Pablo Fernandez, senior vice president, Worldwide Medical Affairs. “Marc’s vast experience and valuable expertise strengthens our neuroscience service offering.”